Highlighting the Role of Obesity and Insulin Resistance in Type 1 Diabetes and Its Associated Cardiometabolic Complications.
Georgios KaramanakosAlexander KokkinosMaria DalamagaStavros LiatisPublished in: Current obesity reports (2022)
Obesity and IR have increasingly been emerging in patients with T1DM. Genetic, epigenetic factors, and subcutaneous insulin administration are implicated in the pathogenesis of this coexistence. Accumulating evidence implies that the concomitant presence of obesity and IR is an independent predictor of worse CVD outcomes. The prevalence of obesity and IR has increased in patients with T1DM. This increase can be partly attributed to general population trends but, additionally, to iatrogenic weight gain caused by insulin treatment. This association might be the missing link explaining the excess CVD burden observed in patients with T1DM despite optimal glycemic control. Data on newer agents for type 2 diabetes mellitus (T2DM) treatment are unraveling novel ways to challenge this aggravating coexistence.
Keyphrases
- glycemic control
- type diabetes
- weight loss
- weight gain
- insulin resistance
- blood glucose
- metabolic syndrome
- body mass index
- high fat diet induced
- birth weight
- risk factors
- cardiovascular disease
- adipose tissue
- skeletal muscle
- combination therapy
- big data
- genome wide
- deep learning
- machine learning
- cardiovascular risk factors